Land: Italië
Taal: Engels
Bron: HMA (Heads of Medicines Agencies)
oxantel embonate 200.28 mg, praziquantel 50 mg, pyrantel embonate 49.94 mg
Vetoquinol
QP52AA51
Tablet
praziquantel, combinations
Dogs
2011-05-19
VETOQUINOL/DOLPAC MEDIUM DOGS/ EUROPEAN RENEWAL JUNE 2011 1/5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Austria Belgium Cyprus Malta Czech Republic Netherlands Greece Portugal Slovakia Hungary Slovenia Germany Finland Dolpac medium dogs tablets France Luxembourg Dolpac 10 comprimé UK-Ireland-Italy Dolpac Tablets for Medium Dogs Spain Poland Dolpac medium dogs tablets for 5-20 kg Denmark Sweden Dolpac vet medium dogs tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains : Active substances Oxantel 200.28 mg (equivalent to 559 mg of oxantel embonate) Pyrantel 49.94 mg (equivalent to 144 mg of pyrantel embonate) Praziquantel 50.00 mg Excipient to one 950 mg divisible tablet Excipients For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet Pale yellow to yellow oblong tablet with breaking line. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For curative treatment of dogs harbouring mixed parasitic infestations with the following adult stages of nematode and cestode species: Nematodes: _ _ _ _ _Toxocara canis _ _ _ _ _ _Toxascaris leonina_ _ _ _ _ _Ancylostoma caninum_ _ _ _ _ _Uncinaria stenocephala_ VETOQUINOL/DOLPAC MEDIUM DOGS/ EUROPEAN RENEWAL JUNE 2011 2/5 _ _ _ _ _Trichuris vulpis_ Cestodes: _ _ _ _ _Dipylidium caninum _ _ _ _ _ _Taenia _spp _ _ _ _ _ _ _Echinococcus multilocularis_ _ _ _ _ _Echinococcus granulosus _ 4.3 CONTRAINDICATIONS See section 4.8 4.4 SPECIAL Lees het volledige document